STRucturation of Transcript Analysis of Genes Involved in Hereditary Cancers
Launched by UNIVERSITY HOSPITAL, ROUEN · Feb 28, 2025
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
The clinical trial titled "STRucturation of Transcript Analysis of Genes Involved in Hereditary Cancers" is studying how better understanding of genetic information can help identify individuals at risk for certain types of cancer, such as breast, ovarian, and digestive cancers. The goal is to improve the way doctors interpret genetic variations that can influence a person's cancer risk and treatment options. Currently, many important genetic tests are not done together due to a lack of resources, which means some cases may be missed. This trial aims to create a reliable system for conducting these tests routinely, which could lead to better care for patients.
To participate in this study, you must be over 18 years old and have been seen in an oncogenetics consultation where you discussed your risk for hereditary cancers. You also need to give your informed consent to take part in the genetic analysis. Participants can expect to undergo genetic testing that will help researchers understand how these tests can better inform cancer prevention and treatment. It’s important to know that this trial is open to all genders and is currently recruiting participants.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Over 18 years of age
- • Patients seen in oncogenetic consultations and who have given their informed consent for genetic analysis in the context of a major predisposition to breast, ovarian or digestive cancer.
- • Person who has read and understood the information note and does not object to taking part in the study
- • Membership of a social security scheme
- Exclusion Criteria:
- • Minors
- • Persons deprived of their liberty or adults under guardianship or incapable of giving their consent
- • Failure to obtain informed consent
About University Hospital, Rouen
The University Hospital of Rouen is a leading medical institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent academic hospital, it integrates cutting-edge medical education with patient care, fostering an environment where clinical research is paramount. With a multidisciplinary team of expert clinicians and researchers, the hospital focuses on a wide range of therapeutic areas, aiming to improve patient outcomes and contribute to the global medical community. The University Hospital of Rouen is committed to ethical standards and rigorous scientific methodologies, ensuring the highest quality of care and research integrity in all its clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Caen, , France
Lille, , France
Patients applied
Trial Officials
Claude HOUDAYER, Professor
Principal Investigator
Molecular Genetics Department, UH of Rouen
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported